COVID-19: Scientists hail T-cells after research proves antibiotics might disappear

As world races to develop antibiotics against coronavirus, a recently released data has thrown spotlight onto T-Cells. T-Cells, which are a major component of human immune system, t only reminded that body’s defences rely on a lot more than antibiotics but proved that body’s inbuilt defenders stay for a longer period of time than syntic antibiotics.

Pharmaceutical brands laud T-Cells 

Major Pharmaceutical brands including AstraZeneca Plc, Pfizer Inc. and partner BioNTech SE, as well as China's CanSi Biologics Inc., have all hailed presence of se white blood cells in ir vaccine recipients. Paul Griffin, an associate professor of medicine at University of Queensland, who is leading clinical research of two potential COVID-19 vaccines in Australia has asserted that antibodies are only a very small part of picture.

Read: Coronavirus LIVE Updates: India's Tally Crosses 12-lakh; Kerala Mulls Statewide Lockdown

Read: Study Finds Finances Of School Teachers Severely Impacted Due To Coronavirus

As pandemic took world by storm, scientists increased ir focus on anti-biotics, proteins that kill foreign invaders in human body.  However, later studies published in journal Science showed that y wane quickly in patients with mild disease, giving a major blow to researchers who were pitched m as immunity boosters.

On or hand, T Cells were found to kill virus-infected cells, remember past diseases for decades and immediately rouse ‘new soldiers in battlefield’. An example of efficiency of T-Cell was found in people who were infected with SARS epidemic in 2003. In addition, T-cells were able to recognize and respond to disease, even today. This has w given hope to scientists that se cells might be able to bolster those patient’s defence against COVID-19.

Read: MP Minister Tests Coronavirus Positive

Read: WHO Expert Says Don't Expect First Coronavirus Vaccinations Until Early 2021